Best in Biotech 15 Oct 2025 Biotech in Luxembourg: five companies that have made their name …interact with T cells to produce Treg cells, which, in turn suppress the harmful activity of effector Teff cells, balancing the immune system. In its pipeline, Tolerogenics has three recombinant… October 15, 2025 - 9 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 18 Jan 2018 France Gets Ready to Test CAR-Treg Cells to Avoid Transplant Rejection …to take its first cell therapy to clinical trials. The treatment, called HLA-A2 CAR-Treg, is intended for the prevention of chronic rejection after organ transplantation. Out of the €5M needed… January 18, 2018 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
Interview 12 Jun 2017 This Italian Academic-turned-CEO also Launched 7 Cancer Drugs at GSK …cancer and on gene therapy, cell therapy and oncolytic viruses. What was it about GammaDelta’s technology that convinced you to join the company? The possibility to transform the treatment of… June 12, 2017 - 9 minutesmins - By Evelyn Warner Share WhatsApp Twitter Linkedin Email
In Depth 6 Oct 2023 Will the U.S. Cancer Moonshot program land its target to halve cancer death rates? …to do it with the RNA. But that’s still the big challenge that we hope to solve within the next year or two.” As part of the grant, $25 million… October 6, 2023 - 10 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 25 Jan 2024 The trends that will shape the biotech industry in 2024 …at the AI technology and the data they have at their disposal to find the most efficient way to exploit these assets. RNA technology sophistication The field now encompasses various… January 25, 2024 - 13 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
In Depth 8 May 2024 New treatment for pulmonary hypertension: what biotech holds in store? …hypertension remains a challenging disease to treat. The disease’s heterogeneity means that effective treatment requires precise tailoring. In this article, we delve into the new treatment advances in pulmonary hypertension…. May 8, 2024 - 8 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
Sponsored 13 Nov 2017 Top 5 Things to Know About Immunotherapies – A Review …is the first step, and then there are other technologies that might be integrated in the anti-cancer movement, like CRISPR Cas9″ – Etienne Drouet Drugs that support checkpoint inhibitors seem… November 13, 2017 - 13 minutesmins - By Larissa Warneck-Silvestrin Share WhatsApp Twitter Linkedin Email
In Depth 14 Sep 2023 Righting wrongs: genetic justice for Henrietta Lacks …they argued that although Henrietta Lacks’ cells were collected at a time when laws on informed consent did not exist, the biotech company continued to get lucrative even after the… September 14, 2023 - 7 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Interview 22 Feb 2018 Could a New Approach Help Us to Overcome Resistance to HIV Treatment? …immune system to kill infected cells. However, he again highlighted that even this approach cannot guarantee that all HIV-infected cells will be killed, putting the patient at risk of remission…. February 22, 2018 - 4 minutesmins - By Alex Dale Share WhatsApp Twitter Linkedin Email
In Depth 2 Apr 2025 Beyond amyloid: The search for the next big thing in Alzheimer’s treatment …clearing amyloid. It became clear that amyloid accumulation might not be the whole story — or that, by the time amyloid builds up, it’s already too late to reverse the… April 2, 2025 - 10 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
In Depth 6 Jul 2020 How Immuno-Oncology Contributes to the Fight Against Covid-19 …way of returning to the roots. “The understanding of the immune response was based on its dissection against microbes. That led to the immuno-oncology field, and that led to the… July 6, 2020 - 7 minutesmins - By Maya Chergova Share WhatsApp Twitter Linkedin Email
News and Trends 16 Nov 2020 Innate Immunity in Cancer Gains Recognition with Affimed’s €1.8B Deal …— to trigger the cancer cells’ destruction. The most advanced drug candidate based on this technology is in phase II development for the treatment of various types of blood cancer…. November 16, 2020 - 3 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email